Get started
Mind Medicine (MindMed) Inc.Mind Medicine (MindMed) Inc.Mind Medicine (MindMed) Inc.

Mind Medicine (MindMed) Inc.

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

MNMD chart


Full chart

MNMD upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪622.59 M‬ USD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.99 USD
Net income (FY)
‪−95.73 M‬ USD
Revenue (FY)
0.00 USD
Shares float
‪27.28 M‬
Beta (1Y)
0.95

Employees


Employees (FY)
57
Change (1Y)
+9 +18.75%
Revenue / Employee (1Y)
0.00 USD
Net income / Employee (1Y)
‪−1.68 M‬ USD

About Mind Medicine (MindMed) Inc.


Sector
Health Technology
CEO
Robert Barrow
Headquarters
New York
Website
mindmed.co
Founded
2010
FIGI
BBG00F13HYQ7
Mind Medicine (MindMed), Inc. operates as clinical stage biopharmaceutical company, which engages in developing novel product candidates to treat brain health disorders. The company was founded by Stephen L. Hurst, Scott M. Freeman, Leonard Latchman and Jamon Alexander Rahn on July 26, 2010 and is headquartered in New York, NY.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

MNMD news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of MNMD is 8.49 USD — it has increased by 12.90% in the past 24 hours. Watch Mind Medicine (MindMed) Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Mind Medicine (MindMed) Inc. stocks are traded under the ticker MNMD.
MNMD stock has risen by 35.41% compared to the previous week, the month change is a 61.41% rise, over the last year Mind Medicine (MindMed) Inc. has showed a 215.61% increase.
We've gathered analysts' opinions on Mind Medicine (MindMed) Inc. future price: according to them, MNMD price has a max estimate of 55.00 USD and a min estimate of 16.00 USD. Watch MNMD chart and read a more detailed Mind Medicine (MindMed) Inc. stock forecast: see what analysts think of Mind Medicine (MindMed) Inc. and suggest that you do with its stocks.
MNMD reached its all-time high on Mar 20, 2017 with the price of 154.80 USD, and its all-time low was 0.01 USD and was reached on Dec 26, 2019. View more price dynamics on MNMD chart.
See other stocks reaching their highest and lowest prices.
MNMD stock is 21.31% volatile and has beta coefficient of 0.95. Track Mind Medicine (MindMed) Inc. stock price on the chart and check out the list of the most volatile stocks — is Mind Medicine (MindMed) Inc. there?
Today Mind Medicine (MindMed) Inc. has the market capitalization of ‪239.10 M‬, it has increased by 3.76% over the last week.
Yes, you can track Mind Medicine (MindMed) Inc. financials in yearly and quarterly reports right on TradingView.
Mind Medicine (MindMed) Inc. is going to release the next earnings report on Apr 8, 2025. Keep track of upcoming events with our Earnings Calendar.
MNMD earnings for the last quarter are −0.18 USD per share, whereas the estimation was −0.28 USD resulting in a 35.02% surprise. The estimated earnings for the next quarter are −0.30 USD per share. See more details about Mind Medicine (MindMed) Inc. earnings.
Mind Medicine (MindMed) Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
MNMD net income for the last quarter is ‪−13.68 M‬ USD, while the quarter before that showed ‪−5.85 M‬ USD of net income which accounts for −133.75% change. Track more Mind Medicine (MindMed) Inc. financial stats to get the full picture.
No, MNMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 57.00 employees. See our rating of the largest employees — is Mind Medicine (MindMed) Inc. on this list?
Like other stocks, MNMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Mind Medicine (MindMed) Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Mind Medicine (MindMed) Inc. technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Mind Medicine (MindMed) Inc. stock shows the buy signal. See more of Mind Medicine (MindMed) Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.